Opus Genetics (IRD) Stock Chart & Stock Price History $1.00 +0.01 (+1.01%) Closing price 07/3/2025 03:44 PM EasternExtended Trading$0.98 -0.02 (-1.50%) As of 07/3/2025 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Opus Genetics Stock Price Performance The Opus Genetics (IRD) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 15.97%. In the past month, the stock has decreased 3.85%, reflecting recent market activity. As of the latest close, Opus Genetics traded at $1.00 with a market cap of $59.66 million and volume of 186,072 shares. Receive IRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.39%1 Month Performance-3.85%3 Month Performance+12.85%Year-To-Date Performance-15.97% IRD Stock Chart for Sunday, July, 6, 2025 IRD Chart by TradingView Opus Genetics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$1.00$1.00$1.02$0.98186,072 shs$59.66 million07/03/2025$0.99$1.00+1.01%$1.02$0.98186,072 shs$59.66 million07/02/2025$0.94$0.99+5.33%$1.03$0.93338,031 shs$59.06 million07/01/2025$0.94$0.94-0.23%$1.00$0.90209,328 shs$56.07 million06/30/2025$0.98$0.94-3.53%$0.96$0.93318,100 shs$56.21 million06/27/2025$1.02$0.98-4.25%$1.03$0.97783,289 shs$58.26 million06/26/2025$0.97$1.02+5.13%$1.05$0.969.50 million shs$60.85 million06/25/2025$0.92$0.97+5.06%$0.98$0.92232,165 shs$57.88 million06/24/2025$0.91$0.92+1.91%$0.96$0.91114,445 shs$55.10 million06/23/2025$0.95$0.91-4.62%$0.97$0.91272,203 shs$54.06 million Get the Latest News and Ratings for IRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$0.93$0.95+2.16%$0.97$0.93164,097 shs$56.68 million06/19/2025$0.93$0.93$0.96$0.91184,159 shs$55.48 million06/18/2025$0.92$0.93+0.69%$0.96$0.91184,159 shs$55.48 million06/17/2025$0.94$0.92-1.88%$0.98$0.92310,465 shs$55.10 million06/16/2025$0.97$0.94-2.96%$0.97$0.93223,549 shs$56.16 million06/13/2025$0.99$0.97-2.18%$1.00$0.96249,802 shs$57.87 million06/12/2025$0.99$0.99+0.07%$1.00$0.95196,044 shs$59.16 million06/11/2025$1.02$0.99-2.85%$1.05$0.98266,309 shs$59.12 million06/10/2025$1.05$1.02-2.86%$1.05$1.02406,150 shs$60.85 million06/09/2025$1.04$1.05+0.96%$1.08$1.00479,934 shs$62.64 million06/06/2025$1.00$1.04+4.00%$1.10$0.96706,620 shs$62.05 million06/05/2025$0.99$1.00+1.01%$1.05$0.93752,182 shs$59.66 million Related Companies Semper Paratus Acquisition Stock Price Chart biote Stock Price Chart Inhibrx Biosciences Stock Price Chart Design Therapeutics Stock Price Chart Esperion Therapeutics Stock Price Chart Nanobiotix Stock Price Chart MediWound Stock Price Chart Cardiff Oncology Stock Price Chart I-Mab Stock Price Chart ProQR Therapeutics Stock Price Chart Receive IRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IRD) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
